Linezolid

Product NDC
65145-181
11-digit product format
651450181
Labeler code
65145
Product ID
65145-181_2220c753-e0e8-4797-bce2-34b3c63bd631
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
linezolid
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Labeler
Caplin Steriles Limited
Application
ANDA219558
Marketing category
ANDA
Marketing start
2025-12-23
Substance
LINEZOLID
Active strength
600 mg/300mL
Pharmacologic classes
Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Linezolid
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
LINEZOLID600 mg/300mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiISQ9I6J12J
Rxcui1662285

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
780e0a7c-a57b-4ddb-82c2-fdccbc11064aProduct name920170814
51fd7f50-f4ab-45ea-852e-f4101dca346bProduct name120150622

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
65145-181-01Linezolid300 mL in 1 BAGINJECTION, SOLUTION3001
65145-181-01Linezolid1 in 1 POUCHINJECTION, SOLUTION11
65145-181-10Linezolid10 in 1 CASEINJECTION, SOLUTION101

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1662285linezolid 600 MG in 300 ML InjectionPSN2220c753-e0e8-4797-bce2-34b3c63bd6311
1662285300 ML linezolid 2 MG/ML InjectionSCD2220c753-e0e8-4797-bce2-34b3c63bd6311
1662285linezolid 600 MG per 300 ML InjectionSY2220c753-e0e8-4797-bce2-34b3c63bd6311

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
65145-181-0165145018101300 mL in 1 BAG300 mlHistorical
65145-181-106514501811010 POUCH in 1 CASE (65145-181-10) / 1 BAG in 1 POUCH (65145-181-01) / 300 mL in 1 BAG10 pouch2025-12-23NoNoCurrent